wpf3888a58.gif
wp5ef1ffdb.gif
wp5ef1ffdb.gif
Courses 2011
These courses are for the use of individuals for the purposes of continuing professional development only.
As a condition of downloading these materials and documents, you agree not to use them in order to
gain any financial benefit for any individual, organisation, or company. You also agree not to make
alterations to them in order to pass them off as your own work. Any infringement of these conditions
will result in the withdrawal of that course, and the individual responsible for infringement will be named.
The on-going availability of these courses for the benefit of all in the profession can only be possible
as long as all users abide by the conditions given above. If you become aware that any of these
conditions may have been infringed, please inform us at Judith@judithbrowncpd.co.uk.
If you would like to receive automatic notification when new courses are released, please use the Contact Us
page to send a message containing your email address, and you will be added to the distribution list.
Your details will not be shared with any other individuals, nor companies.

Before downloading any course materials, please take a few minutes to look at the
suggestions on making the most of the courses. Once you have completed a course
You may wish to record this using the course completion log.
wp0a190e75.png
wpfb604bbe.png
wp15dd399d.png
wp2344759e.png
wp3b2be415_0f.jpg
wp0a190e75.png
wp20c24f08.png
wp02145b2c.gif

 

wp0a190e75.png
wp9ddfc264.png
wpbdb74fe4.png
wpd1bdb812.png
wp648912a9.png
wpd34d85f9.png
wpb99ff064.png
wp316dddbd.png
wp743657de.png
wp754a9e1d.png
wp0a190e75.png

Lipid Transport - lipoprotein structure, function & metabolism      Released     23/01/11

Cardiovascular disease is the leading cause of death in developed nations, with substantial evidence documenting the relationship between cardiovascular disease and increased serum cholesterol levels. This course looks at the physiology underpinning the transport of lipids and their role in the body, and provides a starting point for the clinician to develop an understanding of dyslipidaemic conditions.

 

 

 

Dyslipidaemias                                                                                 Released 10/04/11

‘Dyslipidemia’ refers to an abnormality within the lipid profile, encompassing a variety of disorders relating to raised levels in total cholesterol, LDL, or triglycerides, or conversely, lower levels of HDL. The course will examine the reasons why these disorders occur, together with their presentations and implications.

 wp6fb7cf4f.png

 

Statin therapy                                                                                  Released 18/07/11

Statins are one of the single most prescribed drugs today. They are prescribed for long periods of time, giving opportunity for adverse events, including unforeseen changes in the patient's health status. Additionally, they are most commonly used in middle-aged or elderly patients, who tend to be taking many other medications for other problems. This heightens safety concerns, both because the polypharmacy typical of these age groups greatly increases the overall risk of drug-drug interactions, and also because advanced age itself is likely to increased the risk of toxicity. The course will look at the pharmacokinetics and dynamics of these drugs and their clinical use, together with their potential negative effects.

wpb2a00f44.png

wp6fb7cf4f.png

 

wp1cd3c6e1.gif
wp414ae2cd.png
wpdc7024ad.png
wp7a1941af.png
wp7d4efe9c.png
wpe336c33f.png
wp7a1941af.png
wp7d4efe9c.png
wpe336c33f.png

Wernicke-Korsakoff Syndrome                                                         Released 25/07/11

A deficiency of thiamine (vitamin B1) is responsible for the symptom complex manifested in Wernicke-Korsakoff syndrome, and any condition resulting in a poor nutritional state places patients at risk. Heavy, long-term alcohol use is the most common association with Wernicke-Korsakoff syndrome, although it can occur with malabsorption syndromes and generally poor nutrition. It occurs in the 30-70 age group most commonly, and in severe cases the mortality rate is 15%. A significant interference in gait and neurological function is common. This course will look at the aetiology, pathology, and clinical manifestations of this condition.

wpac637c83_0f.jpg
wpfb156b7d.png
wp3156ea36.png
wp0e65455a.png
wp7a1941af.png
wp7d4efe9c.png
wpe336c33f.png